204 related articles for article (PubMed ID: 32033783)
1. Diagnostic delay in wild type transthyretin cardiac amyloidosis - A clinical challenge.
Ladefoged B; Dybro A; Povlsen JA; Vase H; Clemmensen TS; Poulsen SH
Int J Cardiol; 2020 Apr; 304():138-143. PubMed ID: 32033783
[TBL] [Abstract][Full Text] [Related]
2. Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis.
Quarta CC; Solomon SD; Uraizee I; Kruger J; Longhi S; Ferlito M; Gagliardi C; Milandri A; Rapezzi C; Falk RH
Circulation; 2014 May; 129(18):1840-9. PubMed ID: 24563469
[TBL] [Abstract][Full Text] [Related]
3. Identification of wild-type transthyretin cardiac amyloidosis in patients with carpal tunnel syndrome surgery (CACTuS).
Ladefoged B; Clemmensen T; Dybro A; Hartig-Andreasen C; Kirkeby L; Gormsen LC; Bomholt P; Gillmore J; Poulsen SH
ESC Heart Fail; 2023 Feb; 10(1):234-244. PubMed ID: 36193570
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of cardiac amyloidosis among elderly patients with systolic heart failure or conduction disorders.
López-Sainz Á; de Haro-Del Moral FJ; Dominguez F; Restrepo-Cordoba A; Amor-Salamanca A; Hernandez-Hernandez A; Ruiz-Guerrero L; Krsnik I; Cobo-Marcos M; Castro V; Toquero-Ramos J; Lara-Pezzi E; Fernandez-Lozano I; Alonso-Pulpon L; González-López E; Garcia-Pavia P
Amyloid; 2019 Sep; 26(3):156-163. PubMed ID: 31210553
[No Abstract] [Full Text] [Related]
5. Reduced trans-mitral A-wave velocity predicts the presence of wild-type transthyretin amyloidosis in elderly patients with left ventricular hypertrophy.
Yamamura S; Izumiya Y; Ishida T; Onoue Y; Kimura Y; Hanatani S; Araki S; Fujisue K; Sueta D; Kanazawa H; Takashio S; Usuku H; Sugamura K; Sakamoto K; Yamamoto E; Yamamuro M; Yasuda H; Kojima S; Kaikita K; Hokimoto S; Ogawa H; Tsujita K
Heart Vessels; 2017 Jun; 32(6):708-713. PubMed ID: 27882404
[TBL] [Abstract][Full Text] [Related]
6. Suspicion, screening, and diagnosis of wild-type transthyretin amyloid cardiomyopathy: a systematic literature review.
Bay K; Gustafsson F; Maiborg M; Bagger-Bahnsen A; Strand AM; Pilgaard T; Poulsen SH
ESC Heart Fail; 2022 Jun; 9(3):1524-1541. PubMed ID: 35343098
[TBL] [Abstract][Full Text] [Related]
7. Role of Right Ventricular Strain Measured by Two-Dimensional Echocardiography in the Diagnosis of Cardiac Amyloidosis.
Moñivas Palomero V; Durante-Lopez A; Sanabria MT; Cubero JS; González-Mirelis J; Lopez-Ibor JV; Navarro Rico SM; Krsnik I; Dominguez F; Mingo AM; Hernandez-Perez FJ; Cavero G; Santos SM
J Am Soc Echocardiogr; 2019 Jul; 32(7):845-853.e1. PubMed ID: 31078369
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the standard and speckle tracking echocardiographic features of wild-type and mutated transthyretin cardiac amyloidoses.
Minamisawa M; Koyama J; Sekijima Y; Ikeda S; Kozuka A; Ebisawa S; Miura T; Motoki H; Okada A; Izawa A; Ikeda U
Eur Heart J Cardiovasc Imaging; 2016 Apr; 17(4):402-10. PubMed ID: 26873458
[TBL] [Abstract][Full Text] [Related]
9. Wild-Type Transthyretin Cardiac Amyloidosis is Not Rare in Elderly Subjects: the CATCH Screening Study.
Aimo A; Vergaro G; Castiglione V; Fabiani I; Barison A; Gentile F; Ferrari Chen YF; Giorgetti A; Genovesi D; Buda G; Franzini M; Piepoli M; Moscardini S; Rapezzi C; Fontana M; Passino C; Emdin M
Eur J Prev Cardiol; 2024 Mar; ():. PubMed ID: 38456769
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of wild-type transthyretin amyloid cardiomyopathy in Japan: red-flag symptom clusters and diagnostic algorithm.
Inomata T; Tahara N; Nakamura K; Endo J; Ueda M; Ishii T; Kitano Y; Koyama J
ESC Heart Fail; 2021 Aug; 8(4):2647-2659. PubMed ID: 34137515
[TBL] [Abstract][Full Text] [Related]
11. Native T1 and Extracellular Volume in Transthyretin Amyloidosis.
Martinez-Naharro A; Kotecha T; Norrington K; Boldrini M; Rezk T; Quarta C; Treibel TA; Whelan CJ; Knight DS; Kellman P; Ruberg FL; Gillmore JD; Moon JC; Hawkins PN; Fontana M
JACC Cardiovasc Imaging; 2019 May; 12(5):810-819. PubMed ID: 29550324
[TBL] [Abstract][Full Text] [Related]
12. Effects of tafamidis on the left ventricular and left atrial strain in patients with wild-type transthyretin cardiac amyloidosis.
Nishizawa RH; Kawano H; Yoshimuta T; Eguchi C; Kojima S; Minami T; Sato D; Eguchi M; Okano S; Ikeda S; Ueda M; Maemura K
Eur Heart J Cardiovasc Imaging; 2024 Apr; 25(5):678-686. PubMed ID: 38109497
[TBL] [Abstract][Full Text] [Related]
13. The quintessential form of diastolic heart failure in older adults: Wild type transthyretin cardiac amyloidosis.
Driggin E; Maurer MS
Clin Cardiol; 2020 Feb; 43(2):171-178. PubMed ID: 31825134
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics of wild-type transthyretin cardiac amyloidosis: disproving myths.
González-López E; Gagliardi C; Dominguez F; Quarta CC; de Haro-Del Moral FJ; Milandri A; Salas C; Cinelli M; Cobo-Marcos M; Lorenzini M; Lara-Pezzi E; Foffi S; Alonso-Pulpon L; Rapezzi C; Garcia-Pavia P
Eur Heart J; 2017 Jun; 38(24):1895-1904. PubMed ID: 28329248
[TBL] [Abstract][Full Text] [Related]
15. Regional Variation in Technetium Pyrophosphate Uptake in Transthyretin Cardiac Amyloidosis and Impact on Mortality.
Sperry BW; Vranian MN; Tower-Rader A; Hachamovitch R; Hanna M; Brunken R; Phelan D; Cerqueira MD; Jaber WA
JACC Cardiovasc Imaging; 2018 Feb; 11(2 Pt 1):234-242. PubMed ID: 28917675
[TBL] [Abstract][Full Text] [Related]
16. Wild-Type Transthyretin Cardiac Amyloidosis: Novel Insights From Advanced Imaging.
Narotsky DL; Castano A; Weinsaft JW; Bokhari S; Maurer MS
Can J Cardiol; 2016 Sep; 32(9):1166.e1-1166.e10. PubMed ID: 27568874
[TBL] [Abstract][Full Text] [Related]
17. Value of Longitudinal Strain to Identify Wild-Type Transthyretin Amyloidosis in Patients With Aortic Stenosis.
Robin G; Cognet T; Bouisset F; Cariou E; Méjean S; Pradel S; Colombat M; Galinier M; Carrié D; Lairez O;
Circ J; 2021 Aug; 85(9):1494-1504. PubMed ID: 33980765
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of a TTR specific antisense oligonucleotide in patients with transthyretin amyloid cardiomyopathy.
Benson MD; Dasgupta NR; Rissing SM; Smith J; Feigenbaum H
Amyloid; 2017 Dec; 24(4):219-225. PubMed ID: 28906150
[TBL] [Abstract][Full Text] [Related]
19. Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction.
González-López E; Gallego-Delgado M; Guzzo-Merello G; de Haro-Del Moral FJ; Cobo-Marcos M; Robles C; Bornstein B; Salas C; Lara-Pezzi E; Alonso-Pulpon L; Garcia-Pavia P
Eur Heart J; 2015 Oct; 36(38):2585-94. PubMed ID: 26224076
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics and health care resource use of patients at risk for wild-type transthyretin amyloid cardiomyopathy identified by machine learning model.
Bruno M; Sheer R; Reed C; Schepart A; Nair R; Simmons JD
J Manag Care Spec Pharm; 2023 May; 29(5):530-540. PubMed ID: 37121249
[No Abstract] [Full Text] [Related]
[Next] [New Search]
